Back to results
US 2010/0168416 A1Published application
Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
AssigneeRigel Pharmaceuticals, Inc.
InventorsDane Goff, Jing Zhang, Rajinder Singh, Sacha Holland, Jiaxin Yu, Thilo J. Heckrodt, Pingyu Ding, Joane Litvak
Life of this patent
Estimating the term…
Abstract
Polycyclic heteroaryl substituted triazoles and pharmaceutical compositions containing the compounds are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Methods of using the compounds in treating diseases or conditions associated with Axl activity are also disclosed.
Claims24
A process for preparing an aryl-fused cycloheptanone or a heteroaryl-fused cycloheptanone of formula (i):
- wherein Z is an aryl or a heteroaryl and each R1 is independently selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted aralkyl, and optionally substituted heteroarylalkyl;
- wherein the process comprises:
- a) combining a reactant of formula (ii):
- wherein each R2 is independently selected from the group consisting of optionally substituted alkyl, optionally substituted aralkyl, and optionally substituted heteroarylalkyl, with a reactant of formula (iii):
- wherein Z is the aryl or the heteroaryl, as defined above, and each LG is independently a suitable leaving group, in the presence of a protic solvent, an aprotic solvent, and a base to form a product;
- and
- b) subjecting the product of step a) to a basic hydrolytic media followed by acid to form the aryl-fused cycloheptanone or a heteroaryl-fused cycloheptanone of formula (i).
4 more elements
Dependencies are inferred from the claim text.